// App-Quantinova.ai

PB0642 : The use of plasminogen activator inhibitor-1 specific Affimers as a tool to modulate fibrin clot properties and thrombosis risk

Researchers

Presenter

  • R. Altalhi

Principal Investigators

  • K. Naseem

  • R. Ajjan

Medical Centers

  • University of Leeds, Leeds, United Kingdom

  • University of Leeds, LEEDS, England, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

Biomarkers

  • Plasminogen activator ihnibitor-1

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A